BUZZ-U.S. STOCKS ON THE MOVE-Ligand, EndoChoice, CEL-SCI, Chesapeake Energy

Tue Sep 27, 2016 2:08pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, Wall Street rose for the first time in three days on Tuesday, helped by technology and discretionary stocks.

The Dow Jones Industrial Average was up 0.72 percent at 18,226.01, the S&P 500 was up 0.63 percent at 2,159.59 and the Nasdaq Composite was up 0.87 percent at 5,303.283.

** AMGEN INC, $171.25, -1.31 pct

** LIGAND PHARMACEUTICALS INC, $99.87, -11.69 pct

Amgen said its multiple myeloma drug, Kyprolis, did not surpass Takeda Pharmaceutical Co Ltd's Velcade in a head-to-head late-stage study in previously untreated patients.

Ligand gets royalties on Kyprolis sales.

** AMAZON.COM INC, $815.76, +2.08 pct

JP Morgan raised its target price on the online retailer's stock to $1000 from $925.   Continued...